참고문헌
- Anderson AC, Anderson DE: TIM-3 in autoimmunity. Curr Opin Immunol 18:665-9, 2006. https://doi.org/10.1016/j.coi.2006.09.009
- Sabatos CA, Chakravarti S, Cha E, Schubart A, Sanchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ, Kuchroo VK: Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4:1102-10, 2003. https://doi.org/10.1038/ni988
- Lee MJ, Woo MY, Heo YM, Kim JS, Kwon MH, Kim K, Park S: The inhibition of the T-cell immunoglobulin and mucin domain 3 (Tim3) pathway enhances the efficacy of tumor vaccine. Biochem Biophys Res Commun 402:88-93, 2010. https://doi.org/10.1016/j.bbrc.2010.09.121
- Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK: Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415:536-41, 2002. https://doi.org/10.1038/415536a
- Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Manlongat N, Bender O, Kamradt T, Kuchroo VK, Gutiérrez-Ramos JC, Coyle AJ, Strom TB: Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4:1093-101, 2003. https://doi.org/10.1038/ni987
- Liu Y, Shu Q, Gao L, Hou N, Zhao D, Liu X, Zhang X, Xu L, Yue X, Zhu F, Guo C, Liang X, Ma C: Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol 137:288-95, 2010. https://doi.org/10.1016/j.clim.2010.07.012
- Yang L, Anderson DE, Kuchroo J, Hafler DA: Lack of TIM-3 immunoregulation in multiple sclerosis. J Immunol 180:4409-14, 2008. https://doi.org/10.4049/jimmunol.180.7.4409
- Morimoto K, Hosomi S, Yamagami H, Watanabe K, Kamata N, Sogawa M, Machida H, Okazaki H, Tanigawa T, Nagahara H, Noda E, Tominaga K, Watanabe T, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T: Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease. Scand J Gastroenterol 46:701-9, 2011. https://doi.org/10.3109/00365521.2011.568518
- Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M: Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273:16976-84, 1998. https://doi.org/10.1074/jbc.273.27.16976
- Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6:1245-52, 2005. https://doi.org/10.1038/ni1271
- DeKruyff RH, Bu X, Ballesteros A, Santiago C, Chim YL, Lee HH, Karisola P, Pichavant M, Kaplan GG, Umetsu DT, Freeman GJ, Casasnovas JM: T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol 184:1918-30, 2010. https://doi.org/10.4049/jimmunol.0903059
- Iellem A, Colantonio L, Bhakta S, Sozzani S, Mantovani A, Sinigaglia F, D'Ambrosio D: Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells. Eur J Immunol 30:1030-9, 2000. https://doi.org/10.1002/(SICI)1521-4141(200004)30:4<1030::AID-IMMU1030>3.0.CO;2-8
- Su SB, Grajewski RS, Luger D, Agarwal RK, Silver PB, Tang J, Tuo J, Chan CC, Caspi RR: Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest Ophthalmol Vis Sci 48:4616-25, 2007. https://doi.org/10.1167/iovs.07-0233
- Selvan RS, Zhou LJ, Krangel MS: Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol 27:687-94, 1997. https://doi.org/10.1002/eji.1830270317
- Gonzalo JA, Qiu Y, Lora JM, Al-Garawi A, Villeval JL, Boyce JA, Martinez-A C, Marquez G, Goya I, Hamid Q, Fraser CC, Picarella D, Cote-Sierra J, Hodge MR, Gutierrez-Ramos JC, Kolbeck R, Coyle AJ: Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis. J Immunol 179:1740-50, 2007. https://doi.org/10.4049/jimmunol.179.3.1740
- Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, D'Ambrosio D, O'Garra A, Robinson D, Rocchi M, Santoni A, Zlotnik A, Napolitano M: The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 161:547-51, 1998.
- Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C, Sozzani S, Girolomoni G, Cavani A: Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 166:996-1002, 2001. https://doi.org/10.4049/jimmunol.166.2.996
- Montes-Vizuet R, Vega-Miranda A, Valencia-Maqueda E, Negrete-García MC, Velasquez JR, Teran LM: CC chemokine ligand 1 is released into the airways of atopic asthmatics. Eur Respir J 28:59-67, 2006. https://doi.org/10.1183/09031936.06.00134304
- Gombert M, Dieu-Nosjean MC, Winterberg F, Bunemann E, Kubitza RC, Da Cunha L, Haahtela A, Lehtimaki S, Muller A, Rieker J, Meller S, Pivarcsi A, Koreck A, Fridman WH, Zentgraf HW, Pavenstadt H, Amara A, Caux C, Kemeny L, Alenius H, Lauerma A, Ruzicka T, Zlotnik A, Homey B: CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 174:5082-91, 2005. https://doi.org/10.4049/jimmunol.174.8.5082
- Soler D, Chapman TR, Poisson LR, Wang L, Cote-Sierra J, Ryan M, McDonald A, Badola S, Fedyk E, Coyle AJ, Hodge MR, Kolbeck R: CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol 177:6940-51, 2006. https://doi.org/10.4049/jimmunol.177.10.6940
- Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D: Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194:847-53, 2001. https://doi.org/10.1084/jem.194.6.847
- Hoshino A, Kawamura YI, Yasuhara M, Toyama-Sorimachi N, Yamamoto K, Matsukawa A, Lira SA, Dohi T: Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions. J Immunol 178:5296-304, 2007. https://doi.org/10.4049/jimmunol.178.8.5296
- Hastings WD, Anderson DE, Kassam N, Koguchi K, Greenfield EA, Kent SC, Zheng XX, Strom TB, Hafler DA, Kuchroo VK: TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 39:2492-501, 2009. https://doi.org/10.1002/eji.200939274
피인용 문헌
- The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine—The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional C vol.5, pp.2, 2013, https://doi.org/10.3390/toxins5020336
- miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma vol.35, pp.3, 2021, https://doi.org/10.1038/s41375-020-0947-1